These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 24346990)
21. Evaluation of a Common Prescribing Cascade of Calcium Channel Blockers and Diuretics in Older Adults With Hypertension. Savage RD; Visentin JD; Bronskill SE; Wang X; Gruneir A; Giannakeas V; Guan J; Lam K; Luke MJ; Read SH; Stall NM; Wu W; Zhu L; Rochon PA; McCarthy LM JAMA Intern Med; 2020 May; 180(5):643-651. PubMed ID: 32091538 [TBL] [Abstract][Full Text] [Related]
22. Atypical antipsychotic drugs and the risk for acute kidney injury and other adverse outcomes in older adults: a population-based cohort study. Hwang YJ; Dixon SN; Reiss JP; Wald R; Parikh CR; Gandhi S; Shariff SZ; Pannu N; Nash DM; Rehman F; Garg AX Ann Intern Med; 2014 Aug; 161(4):242-8. PubMed ID: 25133360 [TBL] [Abstract][Full Text] [Related]
23. A population-based analysis of the risk of drug interaction between clarithromycin and statins for hospitalisation or death. Mesgarpour B; Gouya G; Herkner H; Reichardt B; Wolzt M Lipids Health Dis; 2015 Oct; 14():131. PubMed ID: 26497728 [TBL] [Abstract][Full Text] [Related]
24. Comparative tolerability of erythromycin and newer macrolide antibacterials in paediatric patients. Principi N; Esposito S Drug Saf; 1999 Jan; 20(1):25-41. PubMed ID: 9935275 [TBL] [Abstract][Full Text] [Related]
25. Co-administration of statins with cytochrome P450 3A4 inhibitors in a UK primary care population. Bakhai A; Rigney U; Hollis S; Emmas C Pharmacoepidemiol Drug Saf; 2012 May; 21(5):485-93. PubMed ID: 22237927 [TBL] [Abstract][Full Text] [Related]
27. Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction. Soumerai SB; McLaughlin TJ; Spiegelman D; Hertzmark E; Thibault G; Goldman L JAMA; 1997 Jan; 277(2):115-21. PubMed ID: 8990335 [TBL] [Abstract][Full Text] [Related]
28. The newer macrolides. Azithromycin and clarithromycin. Zuckerman JM; Kaye KM Infect Dis Clin North Am; 1995 Sep; 9(3):731-45. PubMed ID: 7490441 [TBL] [Abstract][Full Text] [Related]
29. Severe secondary hyperkalemia and arrhythmia from drug interactions between calcium-channel blocker and voriconazole: a case presentation. Zhao X; Zhang C; Zhu L; Wu B; Han Y; Heung M; Zuo L BMC Nephrol; 2021 May; 22(1):172. PubMed ID: 33971831 [TBL] [Abstract][Full Text] [Related]
30. Comparison of Cardiac Events Associated With Azithromycin vs Amoxicillin. Patel H; Calip GS; DiDomenico RJ; Schumock GT; Suda KJ; Lee TA JAMA Netw Open; 2020 Sep; 3(9):e2016864. PubMed ID: 32930780 [TBL] [Abstract][Full Text] [Related]
31. Appraisal of the cardiovascular risks of azithromycin: an observational analysis. Sutton SS; Hyche S; Magagnoli J; Hardin JW J Comp Eff Res; 2017 Sep; 6(6):509-517. PubMed ID: 28960092 [TBL] [Abstract][Full Text] [Related]
32. A Case of Hypotension and Bradycardia Precipitated by Drug Interaction of Clarithromycin and Calcium-Channel Blocker. Agrawal V; Chaudhari S; Sy A; Delatre L J Am Geriatr Soc; 2015 Sep; 63(9):1966-7. PubMed ID: 26389998 [No Abstract] [Full Text] [Related]
33. Clarithromycin versus azithromycin in the treatment of Mediterranean spotted fever in children: a randomized controlled trial. Cascio A; Colomba C; Antinori S; Paterson DL; Titone L Clin Infect Dis; 2002 Jan; 34(2):154-8. PubMed ID: 11740701 [TBL] [Abstract][Full Text] [Related]
34. Dihydropyridine calcium channel blockers and cardiovascular outcomes in elderly patients: a population-based study. Bucci C; Mamdani MM; Juurlink DN; Tu JV Can J Cardiol; 2008 Aug; 24(8):629-32. PubMed ID: 18685743 [TBL] [Abstract][Full Text] [Related]
35. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD). Herath SC; Poole P Cochrane Database Syst Rev; 2013 Nov; (11):CD009764. PubMed ID: 24288145 [TBL] [Abstract][Full Text] [Related]
36. Comparative study of the efficacy and tolerance of azithromycin versus clarithromycin in the treatment of community-acquired pneumonia in adults. Sopena N; Martínez-Vázquez C; Rodríguez-Suárez JR; Segura F; Valencia A; Sabrià M J Chemother; 2004 Feb; 16(1):102-3. PubMed ID: 15078008 [No Abstract] [Full Text] [Related]
37. Novel evidence-based colchicine dose-reduction algorithm to predict and prevent colchicine toxicity in the presence of cytochrome P450 3A4/P-glycoprotein inhibitors. Terkeltaub RA; Furst DE; Digiacinto JL; Kook KA; Davis MW Arthritis Rheum; 2011 Aug; 63(8):2226-37. PubMed ID: 21480191 [TBL] [Abstract][Full Text] [Related]
38. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647 [TBL] [Abstract][Full Text] [Related]
39. Calcium channel blockers and mortality in elderly patients with myocardial infarction. Jollis JG; Simpson RJ; Chowdhury MK; Cascio WE; Crouse JR; Massing MW; Smith SC Arch Intern Med; 1999 Oct; 159(19):2341-8. PubMed ID: 10547174 [TBL] [Abstract][Full Text] [Related]
40. The role of azithromycin and clarithromycin in clinical practice. Goldman MP; Longworth DL Cleve Clin J Med; 1993; 60(5):359-64. PubMed ID: 8403355 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]